Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Syros Pharmaceuticals (NQ: SYRS ) 1.970 +0.010 (+0.51%) Streaming Delayed Price Updated: 12:10 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Syros Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 9 Next > Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged Wrongdoings September 04, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Syros Pharmaceuticals, Inc. (SYRS) Investigation: Bronstein, Gewirtz and Grossman, LLC Encourages Shareholders to Seek Compensation for Alleged Wrongdoings August 27, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Syros Pharmaceuticals to Present at Upcoming Medical and Investor Conferences August 27, 2024 From Syros Pharmaceuticals Via Business Wire Syros Pharmaceuticals's Earnings Outlook March 26, 2024 Via Benzinga SYRS Investors Have Opportunity to Join Syros Pharmaceuticals, Inc. Securities Fraud Investigation with the Schall Law Firm August 20, 2024 From The Schall Law Firm Via Business Wire Crude Oil Down 2%; Paysafe Shares Surge After Q2 Results August 13, 2024 Via Benzinga Exposures Fossil Fuels S&P 500 Gains 1%; Home Depot Earnings Top Views August 13, 2024 Via Benzinga Topics Stocks Exposures US Equities Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July August 13, 2024 Via Benzinga Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome August 13, 2024 Syros Pharmaceuticals announces discontinuing enrollment in the SELECT-AML-1 Phase 2 trial due to the low probability of demonstrating superiority. The trial evaluated tamibarotene with venetoclax and... Via Benzinga Why Is Syros Pharmaceuticals (SYRS) Stock Down 62% Today? August 13, 2024 Syros Pharmaceuticals stock is down on Tuesday as SYRS investors react to the company discontinuing enrollment for a clinical trial. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday August 13, 2024 It's time to dive into the biggest pre-market stock movers for Tuesday as we check out all of the hottest news moving shares this morning. Via InvestorPlace Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket August 13, 2024 Via Benzinga Syros Provides Update on SELECT-AML-1 Phase 2 Clinical Trial August 12, 2024 From Syros Pharmaceuticals Via Business Wire Syros Reports Second Quarter 2024 Financial Results and Provides a Business Update July 31, 2024 From Syros Pharmaceuticals Via Business Wire Syros to Report Second Quarter 2024 Financial Results on Wednesday, July 31, 2024 July 24, 2024 From Syros Pharmaceuticals Via Business Wire Syros to Host Webcast Event on Higher-Risk Myelodysplastic Syndrome and the Opportunity for Tamibarotene to Become the New Frontline Standard-of-Care for Patients with RARA Gene Overexpression June 13, 2024 From Syros Pharmaceuticals Via Business Wire SYRS Stock Earnings: Syros Pharmaceuticals Beats EPS for Q1 2024 May 14, 2024 SYRS stock results show that Syros Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Syros Reports First Quarter 2024 Financial Results and Provides a Corporate Update May 14, 2024 From Syros Pharmaceuticals Via Business Wire Syros to Participate in Upcoming Investor Conferences May 07, 2024 From Syros Pharmaceuticals Via Business Wire Syros to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024 May 07, 2024 From Syros Pharmaceuticals Via Business Wire Crude Oil Down Over 1%; Cognyte Software Shares Plummet April 09, 2024 U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0.46% to 38,713.72 while the NASDAQ fell 0.24% to 16,215.32. The S&P 500 also... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 12 Health Care Stocks Moving In Tuesday's Intraday Session April 09, 2024 Via Benzinga Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression April 09, 2024 From Syros Pharmaceuticals Via Business Wire Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 09, 2024 Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free Via Benzinga Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 02, 2024 From Syros Pharmaceuticals Via Business Wire Top 3 Health Care Stocks You'll Regret Missing This Month April 02, 2024 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga SYRS Stock Earnings: Syros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023 March 27, 2024 SYRS stock results show that Syros Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. Via InvestorPlace Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update March 27, 2024 From Syros Pharmaceuticals Via Business Wire Syros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial March 25, 2024 From Syros Pharmaceuticals Via Business Wire Earnings Scheduled For March 27, 2024 March 27, 2024 Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.